Help Us Fight
Coronavirus
You can support our groundbreaking COVID-19
research by making a contribution today.
On a college football Saturday in the 1990s, when ISB co-founder and biotech pioneer Dr. Lee Hood was still at the University of Washington, he delivered a lecture. In the audience was Carole Ellison and her husband, Bill, who were Huskies football season ticket holders. “By happenstance, we signed up to hear him speak,” she recalled. “He was one of four people giving lectures. We chose him. I was so impressed with his enthusiasm and genius and ability to look into the future and see things the rest of us can’t in the health and science fields. I never forgot that experience. His brilliance was remarkable.”
Several years later, Bill passed away from Alzheimer’s disease. Nick Newcombe operated a company that provided elder and chronic care services. “We became friends in the process,” she said of Newcombe, who is now the director of development at ISB.
“It’s synchronicity,” said Ellison, a poet, of the dual paths that came together at ISB.
Newcombe kept in contact with his friend and told her of the research happening at the Seattle non-profit and the emerging field of bioinformatics.
“What an opportunity,” said Ellison, who last week was celebrated at an ISB ceremony for creating and funding the K. Carole Ellison Fellows in Bioinformatics.
“This is monumental for fundraising at ISB,” said Newcombe. “This is the first time in our history that we have had a fellowship 100 percent funded by a philanthropist, and this is the latest way in which Carole has made a significant impact on the science of ISB.”
The recently unveiled fellows program funds two young scientists researching bioinformatics.
Carole Ellison, center, poses with Anat Zimmer, left, and Tomasz Wilmanski.
The inaugural fellows are Anat Zimmer, who Ellison calls “brilliant,” and Tomasz Wilmanski, who she said “is an amazing mind.” “It’s so exciting to be part of their lives and help them along in their careers,” she said.
“I am honored and grateful to be a K. Carole Ellison Fellow in Bioinformatics,” said Zimmer. “It provides me the opportunity to be in the right place at the right time to be part of amazing science. Carole is such an inspiring, kind and warm person, and we connected on a personal level. I feel blessed for that.”
“Receiving the K. Carole Ellison Fellowship is a great opportunity, and allows me to bridge my background in nutrition and biology with various computational approaches used at ISB,” said Wilmanski. “It was also a pleasure to thank Carole in person during last week’s reception, and to meet her close friends and family.
While Ellison is responsible for ISB’s first-ever fully funded fellowship, her support of ISB has been steady for years, and was fueled by Hood’s pioneering work in P4 medicine and 21st century health care.
“The subject of wellness vs. sickness and heading off disease in advance makes much more sense than waiting for disease, putting on Band-Aids and hoping for the best,” said Ellison.
“I see it as leading edge, and it’s fun to be a part of it.”
As part of a massive nationwide effort, ISB is leading a multi-site consortium for the NIH RECOVER (Researching COVID to Enhance Recovery) Initiative. The Pacific Northwest consortium is made up of ISB, Providence, Swedish, and University of Washington School of Medicine.
Dr. Jim Heath was announced as a newly elected Fellow of the American Academy for Cancer Research (AACR) Academy Class of 2022. “I am honored and humbled to be recognized as part of this renowned group of researchers who have done so much to move our understanding of cancer forward,” Heath said.
Researchers have identified several factors that can be measured at the initial point of COVID-19 diagnosis that anticipate if a patient is likely to develop long COVID. They also found that mild cases of COVID-19, not just severe cases, are associated with long COVID. Their findings were published by the journal Cell.
You can support our groundbreaking COVID-19
research by making a contribution today.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.